Compounds > 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one

3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one and Glioblastoma

3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one has been researched along with Glioblastoma* in 1 studies

Other Studies

1 other study(ies) available for 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one and Glioblastoma

Article	Year
Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI. Theranostics, 2020, Volume: 10, Issue:16 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Male; Mice; Multiparametric Magnetic Resonance Imaging; Neovascularization, Pathologic; Phosphofructokinase-2; Pyridines; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2020

Article

Year

Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.

Theranostics, 2020, Volume: 10, Issue:16

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Male; Mice; Multiparametric Magnetic Resonance Imaging; Neovascularization, Pathologic; Phosphofructokinase-2; Pyridines; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2020